<http://m.koreaherald.com/view.php?ud=20210702000743>
<http://schema.org/description>
"South Korean central nervous system drug developer SK Biopharmaceuticals CEO Cho Jeong-woo vowed to help the firm attain a value of 50 trillion won ($44.02 billion) by 2030 and make the list of the world&amp;rsquo;s top 10 health care firms.  SK Biopharm shared its latest corporate vision during an online event titled &amp;ldquo;Financial Story,&amp;rdquo; held Friday.   During the event, SK Biopharmaceuticals presented detailed..."
<http://www.koreaherald.com/view.php?ud=20210702000743>